Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

Ranbaxy Laboratories News Editors

News Widget

Display the Ranbaxy Laboratories news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

Ranbaxy Laboratories News

News on Ranbaxy Laboratories (Ticker: RBXLY) continually updated from thousands of sources around the net.

Monday | Newkerala.com

Ranbaxy announces USFDA approval of CIP-Isotretinoin NDA

Gurgaon/Princeton May 28 : Ranbaxy Laboratories Inc. , a wholly owned subsidiary of Ranbaxy Laboratories Limited , today announced that the U.S. Food and Drug Administration has approved Absorica, a novel, patented brand formulation of the acne medication isotretinoin, developed by Cipher, for the treatment of severe recalcitrant nodular acne.

Comment?

Related Topix: Medicine, Medication, Accutane, Isotretinoin (generic), Biotech, Ranbaxy Laboratories, Healthcare Industry, Food and Drug Administration, Dermatology

Mon May 21, 2012

BioSpace

Ranbaxy Laboratories Plans to Relaunch Skin Drug in the US

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia India's largest drug maker Ranbaxy Laboratories plans to re-launch its former flagship skincare brand Sotret in the US, that has been banned for almost four years, through a ... (more)

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, Marketing

Wed May 09, 2012

Drugs.com

Ranbaxy Sales Grew Over 55% With Improvement in Base Business Profitability

The Board of Directors of Ranbaxy Laboratories Limited , at their meeting held today, took on record the unaudited results for the Quarter ended March 31, 2012 under Indian GAAP.

Comment?

Related Topix: Biotech, Ranbaxy Laboratories, Healthcare Industry, Medicine, Lipitor, Atorvastatin (generic), Medication, Malaria, Health

Express India

Ranbaxy Q1 net zooms four-fold at Rs 1,247 cr

Jobs Commodities Automobiles Insurance Real Estate Travel & Tourism Health & Pharma Lifestyle Media Power Telecom Infotech Retail Infrastructure Editor's Picks New Delhi : Drug major Ranbaxy Laboratories today said its consolidated net profit surged over four-fold to Rs 1,246.76 crore during the first quarter ended March 31, 2012, over the same ... (more)

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Tue May 08, 2012

India.com

Ranbaxy reappoints Arun Sawhney as CEO

New Delhi: Drug major Ranbaxy Laboratories on Tuesday said its shareholders have approved reappointment of Arun Sawhney as CEO and Managing Director of the company for a period of five years.

Comment?

Related Topix: Ranbaxy Laboratories, Biotech, Healthcare Industry

Los Angeles Jobs

Also on Topix